A biotech company that discovers & develops novel therapeutics for modulating the gut microbiome to prevent diseases. Covira awarded 2022 Pepperdine Graziadio Business School's Most Fundable Companies® Covira featured on the cover of Business Worldwide Magazine Surgeon receives prestigious award for groundbreaking clinical research
